Stockscreener 앱 받기
2.85
6.34%
0.17
전일 마감가:
$2.68
열려 있는:
$2.66
하루 거래량:
661.90K
Relative Volume:
1.19
시가총액:
$228.50M
수익:
순이익/손실:
$-124.74M
주가수익비율:
-0.0054
EPS:
-527.5896
순현금흐름:
$-149.71M
1주 성능:
+1.06%
1개월 성능:
-31.49%
6개월 성능:
-68.23%
1년 성능:
-73.78%
1일 변동 폭
$0.00
$0.00
1주일 범위
$2.66
$2.98
52주 변동 폭
$2.66
$14.87
Robostrategy Inc Stock (BBOT) Company Profile
명칭
Robostrategy Inc
전화
857 702 0377
주소
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO
Compare BBOT vs VRTX, REGN, MRNA, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBOT
Robostrategy Inc
|
2.85 | 228.50M | 0 | -124.74M | -149.71M | -527.59 |
VRTX
Vertex Pharmaceuticals Inc
|
535.17 | 135.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
819.09 | 84.33B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
202.63 | 80.90B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
875.76 | 55.07B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
382.27 | 43.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
Robostrategy Inc Stock (BBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-08 | 개시 | JP Morgan | Overweight |
| 2026-06-22 | 재개 | Oppenheimer | Outperform |
| 2026-05-11 | 개시 | Canaccord Genuity | Buy |
| 2026-02-11 | 개시 | Stifel | Buy |
| 2026-01-09 | 개시 | Raymond James | Outperform |
| 2025-12-05 | 개시 | Morgan Stanley | Overweight |
| 2025-09-17 | 개시 | Leerink Partners | Outperform |
| 2025-09-15 | 개시 | H.C. Wainwright | Buy |
| 2025-08-15 | 개시 | Piper Sandler | Overweight |
모두보기
Robostrategy Inc 주식(BBOT)의 최신 뉴스
BridgeBio Oncology: The KRAS Opportunity Hidden In The Selloff (NASDAQ:BBOT) - Seeking Alpha
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com Nigeria
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com India
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com Canada
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com UK
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
BridgeBio Oncology Therapeutics (Nasdaq:BBOT)Stock Analysis - Simply Wall Street
BridgeBio Oncology COO Idan Elmelech Reports RSU Tax Withholding via Share Disposal - Kalkine Media
343 shares withheld for taxes leave BridgeBio Oncology (BBOT) COO with 14,152 shares. - Stock Titan
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Short Interest Update - MarketBeat
Perspective Therapeutics (NYSEAM:CATX)Stock Analysis - Simply Wall Street
BridgeBio Oncology (BBOT) grants 43,700 options to principal accounting officer - Stock Titan
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Receives Average Rating of "Moderate Buy" from Brokerages - marketbeat.com
Price to earnings forward of RoboStrategy, Inc. – LSX:A41MQ2 - TradingView
Opaleye Management Inc. Purchases 646,718 Shares of BridgeBio Oncology Therapeutics, Inc $BBOT - marketbeat.com
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sets New 1-Year LowTime to Sell? - marketbeat.com
RoboStrategy Company Profile & Introduction - Moomoo
BridgeBio Oncology Therapeutics Targets Key Data Milestones for 2026 and 2027 with Focus on BBO-8520 Combo (NASDAQ: BBOT) - Kalkine Media
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Shares Down 9.4%Time to Sell? - marketbeat.com
Stifel cuts BridgeBio Oncology price target on pipeline shift - Investing.com
RoboStrategy CEO: Tesla's robotics edge is manufacturing, not AI - scanx.trade
BOT Should I Buy - Intellectia AI
Cash flow from investing activities of RoboStrategy, Inc. – MUN:S0I - TradingView
Enterprise value to revenue forward of RoboStrategy, Inc. – MUN:S0I - TradingView
RoboStrategy Reports August 31, 2026 Net Asset Value Per Share of $11.35 - Quiver Quantitative
RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026 - The Manila Times
RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026 - marketscreener.com
Tesla (NASDAQ: TSLA) Robotics Edge Lies In Manufacturing, Not AI, RoboStrategy CEO Argues - foreignpolicyjournal.com
Anthropic's Growth Is Reshaping Robotics ValuationsRoboStrategy (NASDAQ:BOT) - Benzinga
How to Value a Robotics Company Beyond RevenueRoboStrategy (NASDAQ:BOT) - Benzinga
EXCLUSIVE: Tesla's Biggest Robotics Advantage Isn't AI, RoboStrategy CEO Says - Yahoo Finance
Tesla's Optimus Trails Figure AI in Production Race, RoboStrategy CEO Says - finance.biggo.com
EXCLUSIVE: Tesla Isn't Leading Humanoid Robotics—Figure AI Is, RoboStrategy CEO Says - Benzinga
RoboStrategy, Inc. Releases First Shareholder Letter - Barchart.com
RoboStrategy Shares Drop After Release of First Shareholder Letter - marketscreener.com
BridgeBio (BBOT) Shares: Finishes 0.66% Up at $9.14 on the Day; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Current UpdateCommon Gap - dars.gov.et
RoboStrategy (Backpack Securities) Team - CryptoRank
Enterprise value to EBIT forward of RoboStrategy, Inc. – LSX:A41MQ2 - TradingView
RoboStrategy tokenized stockxStock Price: Live BOTX/USD Rate, Market Cap & BOTX Price Chart - CoinCodex
BOT/BBD: Convert RoboStrategy, Inc. (BOT) to Barbadian Dollar (BBD) - OKX
Buy RoboStrategy, Inc. (XBOT) with credit card | How to Buy RoboStrategy, Inc. - OKX
RoboStrategy, Inc. Price Today | xBOT Live Price, Chart & Market Cap - okx.com
RoboStrategy(BOT) Stock Options Chain | Quotes & News - Moomoo
xBOT to BND | Convert RoboStrategy, Inc. to Brunei Dollar - OKX
BWP to xBOT | Convert Botswanan Pula to RoboStrategy, Inc. - OKX
RoboStrategy, Inc. Price Today | xBOT Live Price, Chart & Market Cap - OKX
MNT to xBOT | Convert Mongolian Tugrik to RoboStrategy, Inc. - OKX
RoboStrategy (Backpack Securities) - CryptoRank
Historical Data for RoboStrategy (Backpack Securities) in USD - CryptoRank
Robostrategy Inc (BBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
3.98%
자본화:
|
볼륨(24시간):